Invention Grant
US08652546B2 Morinda citrifolia based formulations for regulating T cell immunomodulation in neonatal stock animals
有权
用于调节新生儿动物中的T细胞免疫调节的基于海巴戟天的制剂
- Patent Title: Morinda citrifolia based formulations for regulating T cell immunomodulation in neonatal stock animals
- Patent Title (中): 用于调节新生儿动物中的T细胞免疫调节的基于海巴戟天的制剂
-
Application No.: US12199369Application Date: 2008-08-27
-
Publication No.: US08652546B2Publication Date: 2014-02-18
- Inventor: Benjamin J. Darien , Richard G. Godbee
- Applicant: Benjamin J. Darien , Richard G. Godbee
- Applicant Address: US UT Provo
- Assignee: Tahitian Noni International, Inc.
- Current Assignee: Tahitian Noni International, Inc.
- Current Assignee Address: US UT Provo
- Agent Michael F. Krieger
- Main IPC: A61K36/00
- IPC: A61K36/00 ; A61K36/73 ; A61K39/00 ; A23K1/17 ; A23K1/165
Abstract:
Both liquid and dry form Morinda citrifolia enhanced animal food products are provided for increasing CD8+ T cell activation in new born animals. Both contain M. citrifolia fruit puree and other M. citrifolia plant products.
Public/Granted literature
- US20090068204A1 Morinda citrifolia Based Formulations for Regulating T cell Immunomodulation in Neonatal Stock Animals Public/Granted day:2009-03-12
Information query
